Reg FD Disclosure

UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934     Date of Report (Date of Earliest Event Reported): July 9, 2024     THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter)       Ohio   001-00434   31-0411980 (State or Other Jurisdiction of Incorporation)    (Commission File Number)   (I.R.S. Employer Identification No.)     One Procter & Gamble Plaza , Cincinnati , Ohio 45202   (Address of principal executive offices, including zip code)     513 - 983-1100       (Registrant’s telephone number, including area code)         (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))     Securities registered pursuant to Section 12(b) of the Act:    Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock without Par Value   PG   NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025   PG25   NYSE 0.110% Notes due 2026   PG26D   NYSE 3.25% EUR Notes due 2026   PG26F   NYSE 4.875% EUR notes due May 2027   PG27A   NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028   PG28B   NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030   PG30   NYSE 0.350% Notes due 2030   PG30C   NYSE 0.230% Notes due 2031   PG31A   NYSE 3.25% EUR Notes due 2031   PG31B   NYSE 5.250% GBP notes due January 2033   PG33   NYSE 3.200% EUR Notes due 2034   PG34C   NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041   PG41   NYSE       Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).     Emerging growth company ☐           If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐         ITEM 7.01  REGULATION FD DISCLOSURE   On July 9, 2024, The Procter & Gamble Company (the "Company") announced that its Board of Directors declared a quarterly dividend of  $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2024, to Common Stock shareholders of record at the close of business on July 19, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 19, 2024.     The Company is furnishing this 8-K pursuant to Item 7.01, "Regulation FD Disclosure."     ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS     (d) Exhibits Exhibit Number   Description 99.1   Dividend News Release by The Procter & Gamble Company dated July 9, 2024. 104   Cover Page Interactive Data File (embedded within the Inline XBRL document)    SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.          THE PROCTER & GAMBLE COMPANY           BY: /s/ Sandra T. Lane                     Sandra T. Lane          Assistant Secretary      July 9, 2024       INDEX TO EXHIBIT(S)    Exhibit Number   Description   99.1   Dividend News Release by The Procter & Gamble Company dated July 9, 2024 .